FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pascal Jézéquel

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Devices

Oligonucleotide Array Sequence Analysis

Procedures

Co-author Network

Publications

TOP 3
Pascal Jézéquel; Gabriel Ricolleau; Loïc Campion; Jean-Sébastien Frénel; Wilfried Gouraud; Catherine Guérin-Charbonnel; Mario Campone
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
Mathilde Romagnoli; David C Seldin; Margaret L Seldin; Sophie Barillé-Nion; Karine Belguise; Dany Chalbos; Pascal Jézéquel; Esther Landesman-Bollag; Xiaobo Wang; Ziyang Yu; Gail E Sonenshein
Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.
Pascal Jézéquel; Marie-Pierre Joalland; Marie-Lise Jourdan; Delphine Loussouarn; Pierre-Marie Martin; Pascal Roy; Frédérique Spyratos; Jean André; Loïc Campion; Mario Campone; Antoine Carlioz; Agnès Chassevent; Françoise Descotes; Catherine Grenot; Catherine Guérin-Charbonnel; Gabriel Ricolleau
Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pascal Jézéquel (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Pascal Jézéquel; Gabriel Ricolleau; Loïc Campion; Jean-Sébastien Frénel; Wilfried Gouraud; Catherine Guérin-Charbonnel; Mario Campone
bc-GenExMiner 3.0: new mining module computes breast cancer gene expression correlation analyses.
Database : the journal of biological databases and curation 2013;2013():bas060.
2012: Mathilde Romagnoli; David C Seldin; Margaret L Seldin; Sophie Barillé-Nion; Karine Belguise; Dany Chalbos; Pascal Jézéquel; Esther Landesman-Bollag; Xiaobo Wang; Ziyang Yu; Gail E Sonenshein
Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by Blimp-1-dependent repression of BMP-5.
Cancer research 2012;72(23):6268-78.
2012: Pascal Jézéquel; Marie-Pierre Joalland; Marie-Lise Jourdan; Delphine Loussouarn; Pierre-Marie Martin; Pascal Roy; Frédérique Spyratos; Jean André; Loïc Campion; Mario Campone; Antoine Carlioz; Agnès Chassevent; Françoise Descotes; Catherine Grenot; Catherine Guérin-Charbonnel; Gabriel Ricolleau
Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study.
International journal of cancer. Journal international du cancer 2012;131(2):426-37.
2012: Françoise Descotes; Catherine Grenot; Catherine Guérin-Charbonnel; Catherine Guette; Pascal Jézéquel; Marie-Lise Jourdan; Didier Lanoë; Florence Lerebours; Pierre-Marie Martin; Marjorie Adams; Jean André; Loïc Campion; Mario Campone; Antoine Carlioz; Agnès Chassevent; Frédérique Spyratos; Isabelle Zanella-Cleon; Gabriel Ricolleau
Identification of potential prognostic biomarkers for node-negative breast tumours by proteomic analysis: a multicentric 2004 national PHRC study.
International journal of oncology 2012;41(1):92-104.
2012: Pascal Jézéquel; Christophe Leux; Gabriel Ricolleau; Mario Campone; Wilfried Gouraud; Catherine Guérin-Charbonnel; Loïc Campion
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
Breast cancer research and treatment 2012;131(3):765-75.
2011: Mario Campone; Catherine Charbonnel; Olivier Coqueret; Cécile Couriaud; Freddy Gautier; Wilfried Gouraud; Morgan Grau; Yannis Guillemin; Pascal Jézéquel; Sophie Barillé-Nion; Benjamin Barré; Frédérique Braun; Loïc Campion; Bélinda Noël; Philippe Juin
c-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1.
Molecular cancer 2011;10():110.
2011: Ahmed Hamaï; Pascal Jézéquel; Lorenzo Memeo; Tiziana Perin; Pascale Pignon; Isabelle Raimbaud; Maha Ayyoub; Loïc Campion; Mario Campone; Vincenzo Canzonieri; Jean-Marc Classe; Cristina Colarossi; Karine Duperrier-Amouriaux; Danila Valmori
Antibody responses to NY-ESO-1 in primary breast cancer identify a subtype target for immunotherapy.
PloS one 2011;6(6):e21129.
2009: Michel Chérel; Loïc Campion; Stéphane Bézieau; Mario Campone; Josiane Charrier; Joëlle Gaschet; Gabriel Ricolleau; Wilfried Gouraud; Catherine Charbonnel; Pascal Jézéquel
Molecular screening of interleukin-6 gene promoter and influence of -174G/C polymorphism on breast cancer.
Cytokine 2009;47(3):214-23.
2009: Sébastien Salas; Pascal Jézéquel; Loic Campion; Jean-Laurent Deville; Frédéric Chibon; Catherine Bartoli; Jean-Claude Gentet; Catherine Charbonnel; Wilfried Gouraud; Brigitte Voutsinos-Porche; Anne Brouchet; Florence Duffaud; Dominique Figarella-Branger; Corinne Bouvier
Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2.
International journal of cancer. Journal international du cancer 2009;125(4):851-60.
2009: Pascal Jézéquel; Mario Campone; Henri Roché; Wilfried Gouraud; Catherine Charbonnel; Gabriel Ricolleau; Florence Magrangeas; Stéphane Minvielle; Jean Genève; Anne-Laure Martin; Régis Bataille; Loïc Campion
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Breast cancer research and treatment 2009;116(3):509-20.
2009: D Loussouarn; L Campion; F Leclair; Mario Campone; C Charbonnel; G Ricolleau; W Gouraud; R Bataille; Pascal Jézéquel
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer.
British journal of cancer 2009;101(1):166-73.
2008: Olivier Decaux; Laurence Lodé; Florence Magrangeas; Catherine Charbonnel; Wilfried Gouraud; Pascal Jézéquel; Michel Attal; Jean-Luc Harousseau; Philippe Moreau; Régis Bataille; Loïc Campion; Hervé Avet-Loiseau; Stéphane Minvielle
Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myélome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4798-805.
2008: Mario Campone; Loïc Campion; Henry Roché; Wilfried Gouraud; Catherine Charbonnel; Florence Magrangeas; Stéphane Minvielle; Jean Genève; Anne-Laure Martin; Régis Bataille; Pascal Jézéquel
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.
Breast cancer research and treatment 2008;109(3):491-501.
2006: Gabriel Ricolleau; Catherine Charbonnel; Laurence Lodé; Delphine Loussouarn; Marie-Pierre Joalland; Ralf Bogumil; Sabine Jourdain; Stéphane Minvielle; Mario Campone; Régine Déporte-Fety; Loïc Campion; Pascal Jézéquel
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.
Proteomics 2006;6(6):1963-75.
2004: Pascal Jézéquel; J Pichon; Florence Magrangeas; Stéphane Minvielle; M Millour; Gabriel Ricolleau; S Malvaux
[Manufacture of DNA chips in a laboratory for internal use: legislation and quality assurance].
Annales de biologie clinique 2004;62(3):361-6.
2004: Pascal Jézéquel; Loïc Campion; Marie-Pierre Joalland; M Millour; François Dravet; Jean-Marc Classe; Valérie Delecroix; R Deporte; Pierre Fumoleau; Gabriel Ricolleau
G388R mutation of the FGFR4 gene is not relevant to breast cancer prognosis.
British journal of cancer 2004;90(1):189-93.
2000: Pascal Jézéquel; Marie-Pierre Joalland; G Milano; D Lanoë; Gabriel Ricolleau; E Marie-Christine; R Deporte-Fety
Common DPYD mutation associated with 5-fluorouracil toxicity detected by PCR-mediated site-directed mutagenesis.
Clinical chemistry 2000;46(2):309-10.
1999: F Lellouche; I Dorval; J M Corvisier; Pascal Jézéquel; Loïc Campion
C282Y hemochromatosis mutation does not contribute to hypercoagulability in a factor V Leiden population referred to venous thrombosis.
Blood 1999;93(6):2135-6.
1998: Pascal Jézéquel; M Bargain; F Lellouche; F Geffroy; I Dorval
Allele frequencies of hereditary hemochromatosis gene mutations in a local population of west Brittany.
Human genetics 1998;102(3):332-3.
1996: Anne-Marie Jouanolle; G Gandon; Pascal Jézéquel; Martine Blayau; M L Campion; Jacqueline Yaouanq; Jean Mosser; Patricia Fergelot; B Chauvel; P Bouric; G Carn; N Andrieux; I Gicquel; Jean-Yves Le Gall; Véronique David
Haemochromatosis and HLA-H.
Nature genetics 1996;14(3):251-2.
1996: Pascal Jézéquel; B Chauvel; André LE TREUT; Jean-Yves Le Gall; Véronique David; D Le Lannou; Martine Blayau
Identification of a novel mutation in CFTR gene exon 8 (L375F) in a CUAVD phenotype.
Human genetics 1996;97(4):548-9.
1996: Pascal Jézéquel; Isabelle Guilhem; J P Hespel; André LE TREUT; J Y Gall; H Allannic; Martine Blayau
Identification of a novel mutation (A268G) in exon 8 of the HTR beta gene in a large family with thyroid hormone resistance.
Human mutation 1996;8(4):396.
1995: Pascal Jézéquel; I Dorval; Patricia Fergelot; B Chauvel; André LE TREUT; Jean-Yves Le Gall; D Le Lannou; Martine Blayau
Structural analysis of CFTR gene in congenital bilateral absence of vas deferens.
Clinical chemistry 1995;41(6 Pt 1):833-5.
1995: I Dorval; Pascal Jézéquel; B Chauvel; Christèle Dubourg; Patricia Fergelot; Jean-Yves Le Gall; M Roussey; Martine Blayau
French CF family genotype analysis shows that the R297Q mutation is a rare polymorphism.
Human mutation 1995;6(4):334-5.
1994: I Dorval; Patricia Fergelot; Christèle Dubourg; Pascal Jézéquel; B Chauvel; Jean-Yves Le Gall; André LE TREUT
Rapid detection of 1078 delT mutation by PCR-mediated site-directed mutagenesis: detection of cystic fibrosis carriers in a celtic population.
Clinical chemistry 1994;40(12):2318-9.